Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma

Glioblastoma (GBM) as the most common primary malignant brain tumor exhibits a high incidence and degree of malignancy as well as poor prognosis. Due to the existence of formidable blood–brain barrier (BBB) and the aggressive growth and infiltrating nature of GBM, timely diagnosis and treatment of G...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Danping, Zhang, Huifen, Hu, Genwen, Guo, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204881/
https://www.ncbi.nlm.nih.gov/pubmed/35710493
http://dx.doi.org/10.1186/s12951-022-01479-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204881/
https://www.ncbi.nlm.nih.gov/pubmed/35710493
http://dx.doi.org/10.1186/s12951-022-01479-6

Ejemplares similares